Sign in
Stories
HistoSonics Initiates Renal Tumor Treatment Trial
Share
Advances in Brain Cancer Treatments
Edison System Revolutionizes Liver Tumor...
Overview
API
HistoSonics, Inc. commences treatment of the first patient in a clinical trial to evaluate the safety and efficacy of their non-invasive Edison system for selectively removing renal tumors.
Ask a question
How might the success of this trial influence the development of similar technologies for other types of tumors?
How might this non-invasive technology impact the treatment of renal tumors?
What are the potential implications of this trial for other medical devices designed for tumor removal?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Oct 2023
Nov 2023
Dec 2023
Coverage